Matthew Perrone, Author at Daily Hampshire Gazette - Page 3 of 7

FILE - This Wednesday, Dec. 23, 2020 file photo shows a vial of the Moderna COVID-19 vaccine in the first round of staff vaccinations at a hospital in Denver. On Thursday, Oct. 14, 2021, U.S. health advisers said that some Americans who received Moderna’s COVID-19 vaccine should get a half-dose booster to bolster protection against the virus. (AP Photo/David Zalubowski, File)

News

FDA panel backs low-dose Moderna booster

by Lauran Neergaard Associated Press, and Matthew Perrone Associated PressOctober 14, 2021

This image provided by Merck & Co. shows their new antiviral medication, which the drugmaker said has reduced hospitalizations and deaths for people sick with COVID-19.

News

Merck seeks FDA approval for anti-COVID pill

by Matthew Perrone Associated PressOctober 11, 2021

FILE - In this Sept. 14, 2021, file photo, a syringe is prepared with the Pfizer COVID-19 vaccine at a clinic at the Reading Area Community College in Reading, Pa. An influential panel of advisers to the Centers for Disease Control and Prevention met on Wednesday, Sept. 22, to decide who should get COVID-19 booster shots and when. (AP Photo/Matt Rourke)

News

FDA backs Pfizer booster shots for seniors, high-risk

by Matthew Perrone Associated Press, Lauran Neergaard Associated Press, and Mike Stobbe Associated PressSeptember 22, 2021

This image provided by Abbot in September 2021 shows packaging for their BinaxNOW self test for COVID-19. President Joe Biden is betting on millions more rapid, at-home tests to help curb the latest deadly wave of the COVID-19 pandemic, which is overloading hospitals and threatening to shutter classrooms around the country. But the tests have already disappeared from pharmacy shelves in many parts of the U.S., and manufacturers warn it will take them weeks to ramp up production,...

News

Rapid COVID tests hard to find

by Matthew Perrone Associated PressSeptember 21, 2021

FILE - In this Aug. 26, 2021 file photo, Parsia Jahanbani prepares a syringe with the Pfizer COVID-19 vaccine in a mobile vaccine clinic operated by Families Together of Orange County in Santa Ana, Calif. An international group of scientists is arguing the average person doesn't need a COVID-19 booster yet — an opinion that highlights the intense scientific divide over the question. (AP Photo/Jae C. Hong, File)

News

Some experts rebut booster shot plan

by Lauran Neergaard Associated Press, and Matthew Perrone Associated PressSeptember 13, 2021

FILE - In this March 2, 2021, file photo, pharmacy technician Hollie Maloney loads a syringe with Pfizer's COVID-19 vaccine at the Portland Expo in Portland, Maine. The U.S. gave full approval to Pfizer's COVID-19 vaccine on Monday, Aug. 23, 2021. (AP Photo/Robert F. Bukaty, File)

News

US gives full approval to Pfizer COVID-19 vaccine

by Lauran Neergaard Associated Press, and Matthew Perrone Associated PressAugust 23, 2021

FILE - In this July 22, 2021, file photo, health care worker fills a syringe with the Pfizer COVID-19 vaccine at the American Museum of Natural History in New York. U.S. health officials Wednesday, Aug. 18, recommended all Americans get COVID-19 booster shots to shore up their protection amid the surging delta variant and evidence that the vaccines' effectiveness is falling. (AP Photo/Mary Altaffer, File)

News

CDC calls for COVID booster shots

by Matthew Perrone Associated Press, and Mike Stobbe Associated PressAugust 18, 2021

FILE - A man gets a COVID-19 vaccine at a mass vaccination site at the Natick Mall on Wednesday, Feb. 24, 2021, in Natick, Mass. U.S. experts are expected to recommend COVID-19 vaccine boosters for all Americans, regardless of age, eight months after they received their second dose of the shot, to ensure lasting protection against the coronavirus as the delta variant spreads across the country. An announcement was expected as soon as this week, with doses beginning to be administered...

News

US likely to authorize COVID booster shots

by Zeke Miller Associated Press, and Matthew Perrone Associated PressAugust 17, 2021

In this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administration approved aducanumab, the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn’t been shown to help slow the brain-destroying disease. (Biogen via AP)

News

FDA approves much-debated Alzheimer’s drug

by Matthew Perrone Associated PressJune 8, 2021

FILE - This May 17, 2018 file photo shows packs of menthol cigarettes and other tobacco products at a store in San Francisco. On Thursday, April 29, 2021, the Food and Drug Administration pledged again to try to ban menthol cigarettes, this time under pressure from African American groups to remove the mint flavor popular among Black smokers. (AP Photo/Jeff Chiu, File)

US vows again to ban menthol flavor in cigarettes, cigars

by Matthew Perrone Associated PressApril 29, 2021